Anaesthesiologists, n=22 (26.5%) | Surgeons, n=15 (18.1%) | Fellows/residents, n=46 (55.4%) | |
---|---|---|---|
1 Preoperative measurement of sCr is required for perioperative risk stratification. | 10 [9–10] | 10 [9–10] | 10 [9–10] |
2. Preoperative measurement of sCr is required to define a perioperative nephroprotective strategy for high-risk patients. | 9 [8–10] | 8 [8–9] | 9 [9–10] |
3. Preoperative measurement of sCr is required to define a perioperative anaesthesiological and surgical strategy (e.g. choice of anaesthetics drugs, surgical approach). | 10 [9–10] | 7 [6–8] | 8 [7–10] |
4. Preoperative measurement of sCr might help to identify those patients at high risk to develop AKI and for whom a serial postoperative sCr assessment is needed. | 10 [9–10] | 9 [8–10] | 10 [9–10] |
5. Postoperative measurement of sCr is always required after major oncological abdominal surgery. | 10 [9–10] | 9 [8–10] | 9 [9–10] |
6. Postoperative measurement of sCr should be more systematic in those patients at high risk to develop AKI. | 10 [9–10] | 9 [8–10] | 9 [9–10] |
7. Doubling of postoperative sCr from the baseline preoperative value identifies AKI and is a severe condition that affects the short- and long-term prognosis of patients. | 10 [9–10] | 9 [9–10] | 9 [9–10] |
8. An increase in postoperative sCr of 0.3 mg/dl from the baseline preoperative value identifies AKI and is a severe condition that affects the short- and long-term prognosis of patients. | 9 [9–10] | 7 [5–9] | 7 [6–9] |
9. Postoperative AKI is a dangerous condition that might affect the patient’s long-term kidney function leading to CKD or ESRD. | 10 [9–10] | 9 [7–10] | 9 [7–9] |
10. In patients with postoperative AKI, long-term follow-up evaluation of renal function and specialist nephrology referral might be required. | 9 [8–10] | 8 [8–10] | 8 [8–10] |